Insmed's treatment-resistant lung disease drug gets FDA approval #MethadoneClinicsUSA (Reuters) - The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first ... pic.twitter.com/YYQzKViyfY
— Derek Littler (@methadoneUSA) September 29, 2018
Source: @methadoneUSA September 29, 2018 at 03:58PM
More info Methadone Clinics USA
No comments:
Post a Comment